S&P 500   4,524.67 (-0.55%)
DOW   35,536.20 (-0.19%)
QQQ   373.73 (-0.94%)
AAPL   149.19 (-0.19%)
MSFT   308.84 (-0.62%)
FB   322.50 (-5.67%)
GOOGL   2,745.09 (-3.26%)
TSLA   902.66 (+0.97%)
AMZN   3,350.94 (-2.45%)
NVDA   227.28 (+0.16%)
BABA   178.49 (+0.60%)
NIO   39.28 (-1.73%)
CGC   13.39 (-4.63%)
GE   104.07 (+0.89%)
AMD   118.99 (-0.28%)
MU   67.21 (-2.08%)
T   25.64 (-0.47%)
F   16.33 (-1.33%)
ACB   7.10 (-3.66%)
DIS   168.71 (-1.53%)
PFE   42.80 (-0.14%)
BA   213.68 (-0.31%)
AMC   36.77 (-6.29%)
S&P 500   4,524.67 (-0.55%)
DOW   35,536.20 (-0.19%)
QQQ   373.73 (-0.94%)
AAPL   149.19 (-0.19%)
MSFT   308.84 (-0.62%)
FB   322.50 (-5.67%)
GOOGL   2,745.09 (-3.26%)
TSLA   902.66 (+0.97%)
AMZN   3,350.94 (-2.45%)
NVDA   227.28 (+0.16%)
BABA   178.49 (+0.60%)
NIO   39.28 (-1.73%)
CGC   13.39 (-4.63%)
GE   104.07 (+0.89%)
AMD   118.99 (-0.28%)
MU   67.21 (-2.08%)
T   25.64 (-0.47%)
F   16.33 (-1.33%)
ACB   7.10 (-3.66%)
DIS   168.71 (-1.53%)
PFE   42.80 (-0.14%)
BA   213.68 (-0.31%)
AMC   36.77 (-6.29%)
S&P 500   4,524.67 (-0.55%)
DOW   35,536.20 (-0.19%)
QQQ   373.73 (-0.94%)
AAPL   149.19 (-0.19%)
MSFT   308.84 (-0.62%)
FB   322.50 (-5.67%)
GOOGL   2,745.09 (-3.26%)
TSLA   902.66 (+0.97%)
AMZN   3,350.94 (-2.45%)
NVDA   227.28 (+0.16%)
BABA   178.49 (+0.60%)
NIO   39.28 (-1.73%)
CGC   13.39 (-4.63%)
GE   104.07 (+0.89%)
AMD   118.99 (-0.28%)
MU   67.21 (-2.08%)
T   25.64 (-0.47%)
F   16.33 (-1.33%)
ACB   7.10 (-3.66%)
DIS   168.71 (-1.53%)
PFE   42.80 (-0.14%)
BA   213.68 (-0.31%)
AMC   36.77 (-6.29%)
S&P 500   4,524.67 (-0.55%)
DOW   35,536.20 (-0.19%)
QQQ   373.73 (-0.94%)
AAPL   149.19 (-0.19%)
MSFT   308.84 (-0.62%)
FB   322.50 (-5.67%)
GOOGL   2,745.09 (-3.26%)
TSLA   902.66 (+0.97%)
AMZN   3,350.94 (-2.45%)
NVDA   227.28 (+0.16%)
BABA   178.49 (+0.60%)
NIO   39.28 (-1.73%)
CGC   13.39 (-4.63%)
GE   104.07 (+0.89%)
AMD   118.99 (-0.28%)
MU   67.21 (-2.08%)
T   25.64 (-0.47%)
F   16.33 (-1.33%)
ACB   7.10 (-3.66%)
DIS   168.71 (-1.53%)
PFE   42.80 (-0.14%)
BA   213.68 (-0.31%)
AMC   36.77 (-6.29%)
CNSX:CME

CME Group Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.


About CME Group

Canadian Metals Inc. engages in the acquisition, exploration, evaluation, and development of mineral properties in Quebec and New Brunswick, Canada. It explores for silica, zinc, and iron ores. The company holds interests in the Colline Tortue Property that consists of 10 designated claims covering a total area of 569.08 hectares located in the Matapedia region of the Gaspe peninsula of Quebec; the La Chesnaye Lake Silica Property, which comprises 10 claims covering 448 hectares in the province of Québec; the Brunswick Black Shale Property that consists a total of 166 claim units covering approximately 5,479 hectares located in Brunswick Black; the TV Tower Property, which comprises a total of 53 claim units covering approximately 1,157 hectares situated in New Brunswick; and the Mountain Brook Property that comprises a total of 139 claim units covering approximately 4,233 hectares located in New Brunswick. It also holds 20% interest in the Silicate Lake, Seignelay, Lac Robot, Baie Trinité, and Mouchalagane properties located in Québec. The company was founded in 2012 and is headquartered in Val-d'Or, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Financial Exchanges
Sub-Industry
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Optionable

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












CME Group (CNSX:CME) Frequently Asked Questions

What stocks does MarketBeat like better than CME Group?

Wall Street analysts have given CME Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CME Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are CME Group's key executives?

CME Group's management team includes the following people:
  • Mr. Stéphane Leblanc, Founder, Pres & CEO (Age 39, Pay $230k)
  • Ms. Patsie Ducharme CPA, Chief Financial Officer
  • Mr. Beat Frei, VP of Devel. & Project Fin.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include Blueberries Medical (BBM), BioMarin Pharmaceutical (BMRN), nLIGHT (LASR), McDermott International (MDR), Avon Products (AVP), Aurinia Pharmaceuticals (AUPH), Astronics (ATRO), Archrock (AROC), Apollo Global Management (APO) and (APHA).

What is CME Group's stock symbol?

CME Group trades on the CNSX under the ticker symbol "CME."

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does CME Group have?

CME Group employs 4,370 workers across the globe.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

Where are CME Group's headquarters?

CME Group is headquartered at 20 S Wacker Dr, Chicago, Illinois 60606-7431.

How can I contact CME Group?

CME Group's mailing address is 20 S Wacker Dr, Chicago, Illinois 60606-7431. The company can be reached via phone at 312-930-1000.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.